IMNM Immunome, Inc. - Common Stock
$28,96
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$9–$30
97% of range
Analystenbewertung
BUY
20 analysts
Kursziel
$36
+25% upside
P/E (TTM)
-11.9
ROE
-47.0%
Nettogewinnmarge
-3060.0%
IMNM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$28.96
Marktkapitalisierung
$3.28B
P/E (TTM)
-11.9
EPS (TTM)
$-2.43
Umsatz (TTM)
$7M
Dividendenrendite
—
ROE
-47.0%
Verschuldungsgrad
—
52W-Spanne
$9 – $30
IMNM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$7M
2023-12-31
→
2025-12-31
EPS
$-2.43
2020-12-31
→
2025-12-31
Freier Cashflow
$-201M
2020-12-31
→
2025-12-31
Margen
-3060.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
IMNM
Peer-Median
P/E (TTM)
-11.9
—
P/S (TTM) (K/V (TTM))
472.0
18.3
P/B (K/B)
5.2
3.3
Price / FCF (Kurs / FCF)
-16.3
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
IMNM
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-3228.8%
—
Net Profit Margin (Nettogewinnmarge)
-3060.0%
-180.4%
ROA
-46.0%
-36.2%
ROE
-47.0%
-43.7%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
IMNM
Peer-Median
Current Ratio (Liquiditätsgrad)
14.7
9.7
Quick Ratio
14.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
IMNM
Peer-Median
Revenue YoY (Umsatz YoY)
-23.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
IMNM
Peer-Median
IMNM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
20 Analysten
- Starker Kauf 5 25,0%
- Kauf 14 70,0%
- Halten 1 5,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
13 Analysten · 2026-08-18
Median
$36.00
← Unter allen Zielen
$28.96
Tief
$30.00
Hoch
$40.00
Median-Ziel
$36.00
+24,3%
Mittelwert-Ziel
$36.31
+25,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.02%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.48 | $-0.57 | 0.09% |
| 31. Dezember 2025 | $-0.76 | $-0.61 | -0.15% |
| 30. September 2025 | $-0.65 | $-0.59 | -0.06% |
| 30. Juni 2025 | $-0.50 | $-0.54 | 0.04% |
| 31. März 2025 | $-0.52 | $-0.69 | 0.17% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $7M | $9M | $14M | |
| R&D Expense | $177M | $130M | $23M | |
| SG&A Expense | $44M | $33M | $20M | |
| Operating Expenses | $231M | $315M | $124M | |
| Operating Income | $-224M | $-306M | $-110M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-212M | $-293M | $-107M | |
| EPS (Basic) | $-2.43 | $-5.00 | $-5.38 | |
| EPS (Diluted) | $-2.43 | $-5.00 | $-5.38 | |
| Shares (Basic) | 87,350,956 | 58,639,441 | 19,843,651 | |
| Shares (Diluted) | 87,350,956 | 58,639,441 | 19,843,651 | |
| EBITDA | $-222M | $-304M | $-109M |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $653M | $143M | $99M | |
| Prepaid Expense | $7M | $4M | $7M | |
| Current Assets | $661M | $221M | $145M | |
| PP&E (Net) | $15M | $10M | $2M | |
| Other Non-current Assets | $5M | $4M | $100.0K | |
| Total Assets | $683M | $240M | $149M | |
| Accounts Payable | $3M | $14M | $3M | |
| Current Liabilities | $45M | $54M | $22M | |
| Capital Leases | $4M | $5M | $1M | |
| Deferred Tax | $801.0K | $1M | $378.0K | |
| Other Non-current Liabilities | · | · | $1M | |
| Total Liabilities | $49M | $59M | $29M | |
| Common Stock | $11.0K | $6.0K | $4.0K | |
| Paid-in Capital | $1.36B | $697M | $343M | |
| Retained Earnings | $-728M | $-516M | $-223M | |
| AOCI | $0 | $57.0K | $22.0K | |
| Stockholders' Equity | $634M | $181M | $120M | |
| Liabilities + Equity | $683M | $240M | $149M | |
| Shares Outstanding | 113,133,199 | 64,460,829 | 43,251,778 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $457.0K | |
| Stock-based Comp | $26M | $16M | $6M | |
| Other Non-cash | $-7M | $165M | $93M | |
| Operating Cash Flow | $-191M | $-111M | $-8M | |
| CapEx | $10M | $7M | $831.0K | |
| Investing Cash Flow | $61M | $-85M | $-30M | |
| Stock Issued | $46M | $20M | $34.0K | |
| Net Stock Activity | $46M | $20M | $34.0K | |
| Financing Cash Flow | $640M | $241M | $116M | |
| Net Change in Cash | $510M | $45M | $78M | |
| Free Cash Flow | $-201M | $-118M | $-8M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -3228.8% | -3382.4% | -781.4% | |
| Net Margin | -3060.0% | -3240.4% | -761.9% | |
| EBITDA Margin | -3193.3% | -3365.0% | -778.1% | |
| ROA | -46.0% | -150.7% | -123.8% | |
| ROE | -47.0% | -147.9% | -169.6% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 14.7 | 4.1 | 6.6 | |
| Quick Ratio | 14.5 | 2.6 | 4.5 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.2 |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -23.2% | -35.5% | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $7M | $9M | $14M | |
| Net Income TTM | $-212M | $-293M | $-107M | |
| Market Cap | $2.43B | $685M | $463M | |
| P/E | -8.8 | -2.1 | -2.0 | |
| P/S | 350.1 | 75.7 | 33.0 | |
| P/B | 3.8 | 3.8 | 3.9 | |
| P / Tangible Book | 3.8 | 3.8 | 3.9 | |
| P / Cash Flow | -12.7 | -6.2 | -61.2 | |
| P / FCF | -12.1 | -5.8 | -55.1 | |
| Earnings Yield | -11.3% | -47.1% | -50.3% |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $4M | $3M | $3M | $3M | $2M | $1M | $4M | $4M | $4M | $2M | |
| R&D Expense | $60M | $46M | $51M | $49M | $40M | $37M | $48M | $37M | $29M | $15M | $10M | $4M | $6M | $4M | |
| SG&A Expense | $18M | $13M | $12M | $11M | $10M | $11M | $10M | $10M | $7M | $6M | $8M | $4M | $4M | $3M | |
| Operating Expenses | $78M | $59M | $73M | $60M | $50M | $48M | $86M | $53M | $42M | $133M | $98M | $8M | $10M | $7M | |
| Operating Income | $-78M | $-59M | $-73M | $-60M | $-46M | $-45M | $-83M | $-51M | $-40M | $-132M | $-95M | $-5M | $-6M | $-4M | |
| Net Income | $-73M | $-54M | $-70M | $-57M | $-43M | $-42M | $-80M | $-47M | $-36M | $-129M | $-93M | $-4M | $-6M | $-4M | |
| EPS (Basic) | $-0.65 | $-0.48 | $-0.76 | $-0.65 | $-0.50 | $-0.52 | $-1.11 | $-0.78 | $-0.60 | $-2.51 | $-4.21 | $-0.36 | $-0.46 | $-0.35 | |
| EPS (Diluted) | $-0.65 | $-0.48 | $-0.76 | $-0.65 | $-0.50 | $-0.52 | $-1.11 | $-0.78 | $-0.60 | $-2.51 | $-4.21 | $-0.36 | $-0.46 | $-0.35 | |
| Shares (Basic) | 113,272,931 | 113,136,836 | -167,028,008 | 87,957,868 | 87,010,742 | 79,410,354 | -113,046,972 | 60,205,327 | 59,936,703 | 51,544,383 | -16,738,963 | 12,202,335 | 12,197,801 | 12,182,478 | |
| Shares (Diluted) | 113,272,931 | 113,136,836 | -167,028,008 | 87,957,868 | 87,010,742 | 79,410,354 | -113,046,972 | 60,205,327 | 59,936,703 | 51,544,383 | -16,738,963 | 12,202,335 | 12,197,801 | 12,182,478 | |
| EBITDA | $-78M | $-59M | · | $-60M | $-46M | $-44M | · | $-51M | $-40M | $-132M | · | $-5M | $-6M | $-4M |
Bilanz 19
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $218M | $583M | $653M | $273M | $144M | $258M | $143M | $156M | $165M | $270M | $99M | $91M | $38M | $44M | |
| Prepaid Expense | $18M | $12M | $7M | $7M | $9M | $6M | $4M | $4M | $6M | $4M | $7M | $773.0K | $1M | $2M | |
| Current Assets | $538M | $594M | $661M | $280M | $277M | $323M | $221M | $244M | $284M | $313M | $145M | $91M | $40M | $47M | |
| PP&E (Net) | $17M | $17M | $15M | $12M | $11M | $11M | $10M | $7M | $6M | $4M | $2M | $1M | $1M | $916.0K | |
| Other Non-current Assets | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | $568.0K | $100.0K | · | · | · | |
| Total Assets | $565M | $620M | $683M | $299M | $296M | $343M | $240M | $257M | $296M | $320M | $149M | $93M | $41M | $48M | |
| Accounts Payable | $6M | $6M | $3M | $6M | $5M | $9M | $14M | $4M | $7M | $7M | $3M | $3M | $4M | $3M | |
| Current Liabilities | $36M | $27M | $45M | $31M | $23M | $31M | $54M | $40M | $40M | $31M | $22M | $23M | $26M | $25M | |
| Capital Leases | $5M | $4M | $4M | $4M | $4M | $5M | $5M | $2M | $2M | $1M | $1M | · | · | · | |
| Deferred Tax | · | · | $801.0K | · | · | · | $1M | · | · | · | $378.0K | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $122.0K | · | · | |
| Total Liabilities | $40M | $31M | $49M | $35M | $27M | $36M | $59M | $42M | $42M | $34M | $29M | $87M | $32M | $34M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $9.0K | $9.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.38B | $1.37B | $1.36B | $922M | $870M | $865M | $697M | $650M | $642M | $638M | $343M | $136M | $135M | $134M | |
| Retained Earnings | $-855M | $-782M | $-728M | $-658M | $-601M | $-557M | $-516M | $-436M | $-388M | $-352M | $-223M | $-130M | $-126M | $-120M | |
| AOCI | $-333.0K | · | $0 | $0 | $-24.0K | $-3.0K | $57.0K | $70.0K | $2.0K | $4.0K | $22.0K | · | · | · | |
| Stockholders' Equity | $525M | $589M | $634M | $264M | $269M | $307M | $181M | $215M | $254M | $286M | $120M | $6M | $9M | $14M | |
| Liabilities + Equity | $565M | $620M | $683M | $299M | $296M | $343M | $240M | $257M | $296M | $320M | $149M | $93M | $41M | $48M | |
| Shares Outstanding | 113,399,202 | 113,171,396 | 113,133,199 | 91,706,948 | 87,012,835 | 86,955,855 | 64,460,829 | 60,422,062 | 60,013,655 | 59,694,243 | 43,251,778 | 12,202,516 | 12,200,433 | 12,194,184 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $957.0K | $603.0K | $629.0K | $589.0K | $637.0K | $611.0K | $450.0K | $411.0K | $549.0K | $157.0K | $151.0K | $111.0K | $101.0K | $94.0K | |
| Stock-based Comp | $9M | $8M | $8M | $7M | $5M | $6M | $5M | $5M | $3M | $2M | $3M | $1M | $1M | $1M | |
| Other Non-cash | · | $-13M | · | · | · | $-18M | · | · | · | $116M | · | · | · | $27M | |
| Operating Cash Flow | $-62M | $-59M | $-48M | $-41M | $-49M | $-53M | $-42M | $-34M | $-23M | $-11M | $-17M | $-9M | $-6M | $24M | |
| CapEx | $2M | $3M | $4M | $1M | $905.0K | $4M | $1M | $2M | $2M | $2M | $349.0K | $36.0K | $340.0K | $106.0K | |
| Investing Cash Flow | $-304M | $-12M | $-4M | $124M | $-64M | $5M | $10M | $24M | $-82M | $-37M | $-30M | $-36.0K | $-340.0K | $-106.0K | |
| Stock Issued | · | · | $0 | · | · | · | $20M | · | · | · | $0 | $0 | $0 | $34.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $34.0K | |
| Financing Cash Flow | $1M | $-135.0K | $433M | $45M | $-55.0K | $162M | $20M | $305.0K | $694.0K | $219M | $55M | $61M | $0 | $34.0K | |
| Net Change in Cash | $-365M | $-71M | $381M | $129M | $-114M | $114M | $-12M | $-10M | $-104M | $171M | $8M | $52M | $-6M | $24M | |
| Free Cash Flow | · | $-62M | · | · | · | $-57M | · | · | · | $-13M | · | · | · | $24M |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -1157.6% | -1525.5% | · | -1736.1% | -1692.4% | -12857.1% | · | -130.0% | -135.4% | -189.1% | |
| Net Margin | · | · | · | · | -1080.9% | -1423.1% | · | -1618.6% | -1528.0% | -12584.3% | · | -121.9% | -130.4% | -180.6% | |
| EBITDA Margin | · | · | · | · | -1157.6% | -1504.6% | · | -1736.1% | -1692.4% | -12841.8% | · | -130.0% | -135.4% | -185.2% | |
| ROA | -17.0% | -11.2% | · | -20.7% | -14.6% | -12.6% | · | -26.9% | -21.4% | -70.4% | · | -7.0% | -13.8% | -8.9% | |
| ROE | -18.4% | -12.0% | · | -24.0% | -16.6% | -14.1% | · | -42.6% | -27.5% | -86.5% | · | -29.8% | -28.1% | -16.5% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.1 | 21.7 | · | 8.9 | 12.1 | 10.5 | · | 6.2 | 7.1 | 10.2 | · | 4.0 | 1.5 | 1.9 | |
| Quick Ratio | 6.1 | 21.3 | · | 8.7 | 6.3 | 8.4 | · | 3.9 | 4.1 | 8.8 | · | 3.9 | 1.5 | 1.8 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $7M | · | $10M | $12M | $9M | · | $10M | $11M | $11M | · | · | · | · | |
| Net Income TTM | $-228M | $-196M | · | $-190M | $-168M | $-254M | · | $-217M | $-176M | $-144M | · | $-23M | $-27M | $-33M | |
| Market Cap | $2.40B | $2.48B | · | $1.07B | $809M | $585M | · | $883M | $726M | $1.47B | · | $102M | $97M | $61M | |
| P/E | -9.3 | -10.2 | · | -4.8 | -3.9 | -1.5 | · | -3.4 | -3.1 | -6.7 | · | -4.3 | -3.4 | -1.8 | |
| P/S | 598.5 | 356.6 | · | 109.0 | 66.2 | 63.4 | · | 89.5 | 64.7 | 131.3 | · | · | · | · | |
| P/B | 4.6 | 4.2 | · | 4.1 | 3.0 | 1.9 | · | 4.1 | 2.9 | 5.2 | · | 16.8 | 10.3 | 4.4 | |
| P / Tangible Book | 4.6 | 4.2 | · | 4.1 | 3.0 | 1.9 | · | 4.1 | 2.9 | 5.2 | · | 16.8 | 10.3 | 4.4 | |
| P / Cash Flow | · | -42.2 | · | · | · | -11.0 | · | · | · | -131.9 | · | · | · | 2.5 | |
| P / FCF | · | -40.2 | · | · | · | -10.3 | · | · | · | -110.5 | · | · | · | 2.5 | |
| Earnings Yield | -10.8% | -9.8% | · | -20.9% | -25.8% | -65.5% | · | -29.1% | -32.5% | -14.9% | · | -23.0% | -29.1% | -56.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $7M | $9M | $14M | — | — |
| Betriebsgewinnmarge % | -3228.8% | -3382.4% | -781.4% | -738020.0% | 252040.0% |
| Nettoergebnis | $-212M | $-293M | $-107M | $-37M | $-25M |
| Verwässerte EPS | $-2.43 | $-5.00 | $-5.38 | $-3.09 | $-2.14 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 14.7 | 4.1 | 6.6 | 3.1 | 5.8 |
| Quick Ratio | 14.5 | 2.6 | 4.5 | 2.8 | 5.1 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-201M | $-118M | $-8M | $-29M | $-18M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 218 Einreicher · $1.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 38 (-5 vs. Vorquartal) | 25 (-3 vs. Vorquartal) | 68 (-5 vs. Vorquartal) | 60 (+13 vs. Vorquartal) | +8.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $219.412.109 | 10.354.512 | 14,46% | Aktien |
| STATE STREET CORP | $116.431.104 | 5.494.625 | 7,67% | Aktien |
| Redmile Group, LLC | $104.076.592 | 4.911.590 | 6,86% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $97.080.523 | 4.581.431 | 6,40% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $96.441.814 | 4.551.289 | 6,35% | Aktien |
| Driehaus Capital Management LLC | $92.094.685 | 4.346.139 | 6,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $91.744.775 | 4.329.626 | 6,05% | Aktien |
| ENAVATE SCIENCES GP, LLC | $76.576.401 | 3.613.799 | 5,05% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $50.056.190 | 2.361.709 | 3,30% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $42.740.421 | 2.017.009 | 2,82% | Aktien |
| Sofinnova Investments, Inc. | $36.453.496 | 1.720.316 | 2,40% | Aktien |
| READYSTATE ASSET MANAGEMENT LP | $34.027.326 | 1.605.820 | 2,24% | Aktien |
| JPMORGAN CHASE & CO | $28.653.198 | 1.357.265 | 1,89% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28.584.865 | 1.348.979 | 1,88% | Aktien |
| GOLDMAN SACHS GROUP INC | $24.727.098 | 1.166.923 | 1,63% | Aktien |
| Woodline Partners LP | $21.198.434 | 1.000.398 | 1,40% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18.778.430 | 886.193 | 1,24% | Aktien |
| MetLife Investment Management, LLC | $18.203.820 | 859.076 | 1,20% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $16.025.933 | 756.297 | 1,06% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $15.521.929 | 732.512 | 1,02% | Aktien |
| TD Asset Management Inc | $15.241.374 | 719.272 | 1,00% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $15.141.378 | 714.553 | 1,00% | Aktien |
| Candriam S.C.A. | $14.398.131 | 680.132 | 0,95% | Aktien |
| Parkman Healthcare Partners LLC | $12.591.140 | 594.202 | 0,83% | Aktien |
| BANK OF AMERICA CORP /DE/ | $12.311.114 | 580.987 | 0,81% | Aktien |
| MARSHALL WACE, LLP | $9.803.490 | 462.647 | 0,65% | Aktien |
| Qube Research & Technologies Ltd | $9.306.351 | 439.186 | 0,61% | Aktien |
| ALERUS FINANCIAL NA | $8.124.691 | 383.421 | 0,54% | Aktien |
| Granahan Investment Management, LLC | $8.021.305 | 378.542 | 0,53% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $7.623.738 | 359.780 | 0,50% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $7.446.187 | 351.401 | 0,49% | Aktien |
| Rock Springs Capital Management LP | $7.367.043 | 347.666 | 0,49% | Aktien |
| Atom Investors LP | $6.303.792 | 297.489 | 0,42% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $5.870.986 | 277.064 | 0,39% | Aktien |
| FIRST TRUST ADVISORS LP | $5.569.219 | 262.823 | 0,37% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.320.851 | 251.102 | 0,35% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4.913.134 | 231.861 | 0,32% | Aktien |
| CITADEL ADVISORS LLC | $4.748.234 | 224.079 | 0,31% | Aktien |
| Burkehill Global Management, LP | $4.238.000 | 200.000 | 0,28% | Aktien |
| Swiss National Bank | $3.848.104 | 181.600 | 0,25% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3.663.603 | 172.893 | 0,24% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.649.448 | 172.225 | 0,24% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.388.281 | 159.900 | 0,22% | Kaufoption |
| Atika Capital Management LLC | $3.247.092 | 153.237 | 0,21% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $3.226.495 | 152.265 | 0,21% | Aktien |
| FEDERATED HERMES, INC. | $3.011.035 | 142.097 | 0,20% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.919.645 | 133.500 | 0,19% | Aktien |
| CITIGROUP INC | $2.884.340 | 136.118 | 0,19% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.870.000 | 135.451 | 0,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $2.816.279 | 132.906 | 0,19% | Aktien |
| RHUMBLINE ADVISERS | $2.807.216 | 132.479 | 0,18% | Aktien |
| Schonfeld Strategic Advisors LLC | $2.799.007 | 132.091 | 0,18% | Aktien |
| XTX Topco Ltd | $2.683.671 | 126.648 | 0,18% | Aktien |
| Sio Capital Management, LLC | $2.631.120 | 124.168 | 0,17% | Aktien |
| Aristotle Atlantic Partners, LLC | $2.582.107 | 121.855 | 0,17% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.437.280 | 111.444 | 0,16% | Aktien |
| ALPS ADVISORS INC | $2.424.984 | 114.440 | 0,16% | Aktien |
| TEMA ETFS LLC | $2.192.141 | 102.055 | 0,14% | Aktien |
| Bank of New York Mellon Corp | $2.149.153 | 101.423 | 0,14% | Aktien |
| AXA Investment Managers S.A. | $2.108.456 | 180.056 | 0,14% | Aktien |
| JANE STREET GROUP, LLC | $1.981.265 | 93.500 | 0,13% | Kaufoption |
| Trexquant Investment LP | $1.873.005 | 88.391 | 0,12% | Aktien |
| BlackRock, Inc. | $1.790.428 | 84.494 | 0,12% | Aktien |
| BIT Capital GmbH | $1.767.246 | 83.400 | 0,12% | Aktien |
| Rafferty Asset Management, LLC | $1.762.372 | 83.170 | 0,12% | Aktien |
| Neo Ivy Capital Management | $1.713.762 | 80.876 | 0,11% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.574.926 | 74.324 | 0,10% | Aktien |
| Edgestream Partners, L.P. | $1.523.243 | 71.885 | 0,10% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.414.009 | 66.730 | 0,09% | Aktien |
| Freestone Capital Holdings, LLC | $1.283.881 | 60.589 | 0,08% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $1.272.375 | 60.046 | 0,08% | Aktien |
| Ikarian Capital, LLC | $1.271.401 | 60.000 | 0,08% | Aktien |
| SummitTX Capital, L.P. | $1.260.296 | 59.476 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $1.229.020 | 58.000 | 0,08% | Kaufoption |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.222.091 | 57.673 | 0,08% | Aktien |
| BAKER BROS. ADVISORS LP | $1.171.934 | 55.306 | 0,08% | Aktien |
| JANUS HENDERSON GROUP PLC | $1.155.878 | 52.816 | 0,08% | Aktien |
| Erste Asset Management GmbH | $1.094.080 | 52.000 | 0,07% | Aktien |
| Birchview Capital, LP | $1.059.500 | 50.000 | 0,07% | Aktien |
| AlphaQuest LLC | $1.051.833 | 48.968 | 0,07% | Aktien |
| Lido Advisors, LLC | $1.045.536 | 49.341 | 0,07% | Aktien |
| Vanguard Global Advisers, LLC | $1.040.090 | 49.084 | 0,07% | Aktien |
| VANGUARD GROUP INC | $1.023.329 | 47.641 | 0,07% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $1.007.034 | 47.524 | 0,07% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $1.000.740 | 47.227 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $983.216 | 46.400 | 0,06% | Verkaufsoption |
| STATE OF WISCONSIN INVESTMENT BOARD | $962.937 | 45.443 | 0,06% | Aktien |
| Scharf Investments, LLC | $940.603 | 44.389 | 0,06% | Aktien |
| Corient Private Wealth LP | $915.981 | 43.227 | 0,06% | Aktien |
| PROFUND ADVISORS LLC | $903.436 | 42.635 | 0,06% | Aktien |
| Invesco Ltd. | $892.586 | 42.123 | 0,06% | Aktien |
| Magnus Financial Group LLC | $884.873 | 41.759 | 0,06% | Aktien |
| Cerity Partners LLC | $838.700 | 39.580 | 0,06% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $784.030 | 37.000 | 0,05% | Aktien |
| Palumbo Wealth Management LLC | $692.045 | 32.659 | 0,05% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $678.228 | 32.007 | 0,04% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $658.797 | 31.090 | 0,04% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $645.447 | 30.460 | 0,04% | Aktien |
| State of New Jersey Common Pension Fund D | $620.125 | 29.265 | 0,04% | Aktien |
| Campbell & CO Investment Adviser LLC | $563.760 | 26.605 | 0,04% | Aktien |
Unternehmensinsider 27 Insider · 13 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Clay B Siegall | President and CEO | 23. Juli 2026 A | 870.704 | 4 | 0 | $1.749.659 |
| Purnanand D Sarma | President and CEO | 8. Juni 2023 A | 10.500 | 0 | 0 | $0 |
| Max Rosett | Chief Financial Officer | 23. Juli 2026 A | 101.287 | 0 | 1 | $-1.093.800 |
| Corleen M. Roche | Chief Financial Officer | 8. Juni 2023 A | — | 0 | 0 | $0 |
| Richard F Fitzgerald | Chief Financial Officer | 1. Oktober 2020 A | — | 0 | 0 | $0 |
| Philip Tsai | Chief Technical Officer | 23. Juli 2026 A | 81.550 | 0 | 0 | $0 |
| Robert Lechleider | Chief Medical Officer | 23. Juli 2026 A | 69.805 | 0 | 5 | $-2.335.993 |
| Jack Higgins | Chief Scientific Officer | 23. Juli 2026 A | 60.250 | 0 | 0 | $0 |
| Sandra G. Stoneman | CHIEF LEGAL OFFICER & GC | 23. Juli 2026 A | 43.805 | 0 | 0 | $0 |
| Phil Noland Roberts | Chief Technology Officer | 13. Dezember 2023 A | — | 0 | 0 | $0 |
| Bruce Turner | Chief Strategy Officer | 2. Oktober 2023 P | 42.300 | 0 | 0 | $0 |
| Matthew K Robinson | Chief Technology Officer | 8. Juni 2023 A | — | 0 | 0 | $0 |
| Dennis H Giesing | Chief Development Officer | 8. Juni 2023 A | — | 0 | 0 | $0 |
| James P Boylan | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Sandra M Swain | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Philip Wagenheim | Direktor | 10. Juni 2026 A | 341.147 | 0 | 2 | $-1.335.626 |
| Carol Schafer | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Jean Jacques Bienaime | Direktor | 10. Juni 2026 A | 43.415 | 6 | 2 | $147.610 |
| Michael Rapp | Direktor | 2. Oktober 2023 A | 1.071.172 | 0 | 0 | $0 |
| Franklyn G Prendergast | Direktor | 2. Oktober 2023 A | 60.840 | 0 | 0 | $0 |
| Michael Lefenfeld | Direktor | 8. Juni 2023 A | 40.747 | 0 | 0 | $0 |
| Richard A Baron | Direktor | 8. Juni 2023 A | 2.343 | 0 | 0 | $0 |
| John L Lamattina | Direktor | 8. Juni 2023 A | 66.953 | 0 | 0 | $0 |
| Michael Widlitz | Direktor | 28. Mai 2021 A | 51.315 | 0 | 0 | $0 |
| Wistar I Morris III | 10%-Eigentümer | 6. Oktober 2020 C | 38.464 | 0 | 0 | $0 |
| Isaac Barchas | — | 12. August 2026 S | 92.211 | 0 | 10 | $-9.944.909 |
| Kinney Horn | — | 4. August 2026 M | 0 | 0 | 2 | $-2.300.855 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Enavate Sciences GP, LLC, Immunome Aggregator, LP | 22. Dezember 2025 | 4,30% | Änderung | — | SEC |
| Immunome Aggregator, LP, Enavate Sciences GP, LLC | 4. Februar 2025 | 6,00% | Änderung | — | SEC |
| Arsenal Bridge Venture II, LLC, Arsenal Bridge Venture II-B, LLC, Arsenal Bridge Advisors, LLC, RBP Catalyst Fund, L.P., Research Bridge Partners, Inc., Isaac Barchas, James Graham ×2 Einreichungen | 21. August 2024 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 12. Oktober 2023 | — | Erste Einreichung | Passive Anlage | SEC |
| Morphimmune Inc. | 7. Juli 2023 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 42 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 3,91% | 315.648 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,87% | 14.102 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,74% | 168.145 NS | 30. April 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,69% | 3.351 NS | 30. April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,34% | 157.162 NS | 30. April 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,30% | 7.075 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,17% | 955.843 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 127.656 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 113.000 SH | 8. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,12% | 63.318 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 2.689.690 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,07% | 44.221 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 606.588 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 14.653 NS | 30. April 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 68.747 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,06% | 4.805 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 496.351 NS | 31. Mai 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 17.326 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 18.348 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 4.411 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,03% | 9.397 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 42.979 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,03% | 3.758 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.223.884 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 272.423 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,02% | 3.800 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 5.653 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3.920 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 95 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 10.511 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 30.872 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 7.094 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 31.136 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 145.395 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 61.158 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 2.618 NS | 30. April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.752 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 6.695 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 628 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1.576 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.225.694 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.523 SH | 8. August 2026 | Täglich |